Amgen and NSG BioLabs Extend Golden Ticket Award for Singapore Biotech, PairX Bio Wins Residency and Mentorship

AInvestWed, Jul 17, 2024 ET

1min read

AMGN --

PairX Bio has won the Amgen Golden Ticket Award, receiving valuable support from Amgen and NSG BioLabs, as part of a three-year extension of the program. The award highlights Singapore's growing biotech sector, with a doubling of applicants this year. NSG BioLabs, partnering with CapitaLand, plans to expand its lab space to 70,000 square feet, cementing its position as the largest in Southeast Asia. The initiative aims to boost innovation and growth in the industry.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.